Jubilant Pharmova Ltd

Jubilant Pharmova Ltd

JUBLPHARMA

 1,101.10
- 1.91
0.17%
Healthcare
 0.00
(%)1D
Updated: 17 Sep 2025, 03:29:27 pm IST
Stock Score
Open Price
 1,106.46
Prev. Close
 1,103.01
 1,081.81
Day Low
 1,113.24
Day High

 805.74
52 Week Low
 1,303.95
52 Week High

Quick Bite

Price To Earnings Ratio

20.72

Sector PE

57.54

PB Ratio

2.79

Sector PB

5.98

EPS

53.13

Dividend Yield

0.56

Today's Volume

142.268 K

5 Day Avg. Volume

100.484 K

PEG Ratio

0.02

Market Cap.

₹ 17,780.00 Cr.

News & Events

About Jubilant Pharmova Ltd

Jubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company's segments include Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation-Sterile Injectables, Generics, Contract Research, Development and Manufacturing Organisation, Proprietary Novel Drugs, and Management Services. The Radiopharma segment comprises radiopharmaceuticals, including radio pharmacies. The Contract Development and Manufacturing Organisation-Sterile Injectables segment includes contract development and manufacturing organisation-sterile injectables products. The Generics segment includes solid dosage formulations. The Contract Research, Development and Manufacturing Organisation segment includes drug discovery services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment includes patient-focused biopharmaceutical businesses working to address unmet medical needs in oncology and autoimmune diseases.

Jubilant Pharmova Ltd Share Price

Jubilant Pharmova Limited is an India-primarily based totally incorporated pharmaceutical company. The Company's segments encompass Pharmaceuticals, Contract Research and Development Services and Proprietary Novel Drugs. The Pharmaceuticals phase, via absolutely owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and deliver of energetic pharmaceutical ingredients (APIs), strong dosage formulations, radiopharmaceuticals, hypersensitive reaction remedy merchandise and agreement production of sterile injectables and non-sterile merchandise via six production centers in India, United States and Canada and a community of about forty eight radio pharmacies withinside the United States. The Contract Research and Development Services phase affords drug discovery and improvement offerings in addition to medical records software program and carrier solutions. The Proprietary Novel Drugs phase is a patient-targeted biopharmaceutical enterprise operating to cope with unmet scientific wishes in oncology and autoimmune diseases.

Jubilant Pharmova Ltd FAQs

How to Buy Jubilant Pharmova Ltd Share?

up
To purchase Jubilant Pharmova Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Jubilant Pharmova Ltd (ticker symbol: JUBLPHARMA) on the trading platform provided by your broker and purchase the shares.

What's Jubilant Pharmova Ltd share price today?

up
The stock price of Jubilant Pharmova Ltd as of 18 Sep 2025 is ₹1,101.10

What is the Market Cap of Jubilant Pharmova Ltd?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 18 Sep 2025, Jubilant Pharmova Ltd (ticker symbol: JUBLPHARMA) has a market capitalisation of approximately ₹1,77,80,00,00,000.00

What is the PE and PB ratio of Jubilant Pharmova Ltd?

up
Jubilant Pharmova Ltd Ltd's price-to-book ratio as of 18 Sep 2025 is 2.79, reflecting the market's valuation compared to its asset value. As of 18 Sep 2025, the trailing twelve months P/E (price-to-earnings) ratio is 20.72, indicating the market values the company at around ₹20.72 for every ₹1 of earnings

What is the 52 Week High and Low of Jubilant Pharmova Ltd Share?

up
Jubilant Pharmova Ltd Ltd (JUBLPHARMA) hit its 52-week high at ₹1,303.95, and its 52-week low at ₹805.74.
Begin your investment journey today
Login/Register
Start Now